Analysis of protein expression profile of oral squamous cell carcinoma by MALDI-TOF-MS

Anticancer Research

Volumn 33, Issue 3, 2013, Pages 837-846

  Roman, Eric ^a   Lunde, Mai Lill Suhr ^a   Miron, Talia ^b   Warnakulasauriya, Saman ^c   Johannessen, Anne Christine ^d   Vasstrand, Endre Normann ^a   Ibrahim, Salah Osman ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Ionization time of flight mass spectrometry; Mass spectrometry; Matrix assisted laser desorption; Oral squamous cell carcinoma

Indexed keywords

ANNEXIN; BIOLOGICAL MARKER; CYTOKERATIN 1; CYTOSKELETON PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; LIPOCORTIN 2; LIPOCORTIN 5; SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUTH SQUAMOUS CELL CARCINOMA; NORWAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNITED KINGDOM; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANNEXIN A2; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; SERPINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84875886075     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Lambert R, Sauvaget C, de Camargo Cancela M and Sankaranarayanan R: Epidemiology of cancer from the oral cavity and oropharynx. European journal of gastroenterology & hepatology 23(8): 633-641, 2011.
2. Moore SR, Johnson NW, Pierce AM and Wilson DF: The epidemiology of mouth cancer: A review of global incidence. Oral Dis 6(2): 65-74, 2000.
3. Franceschi S, Bidoli E, Herrero R and Munoz N: Comparison of cancers of the oral cavity and pharynx worldwide: Etiological clues. Oral Oncol 36(1): 106-115, 2000.
4. Mork J, Glattre E. Squamous cell carcinomas of the head and neck in Norway, 1953-92: an epidemiologic study of a low-risk population. Cancer Causes Control 9(1): 37-48, 1998.
5. Data were provided by the Office for National Statistics on request, October 2011. Similar data can be found at: http://www.ons.gov.uk/ons/search/ index.html?newquery=cancer+regist rations.
6. Data were provided by ISD Scotland on request, September 2011. Similar data can be found at: http://www.isdscotland.org/Health-Topics/Cancer/ Publications/index.asp#605.
7. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit on request, September 2011. Similar data can be found at: http://www.wales.nhs. uk/sites3/page.cfm?orgid= 242&pid=51358. 2011.
8. The Cancer Registry of Norway 2002: Report. Cancer in Norway 2002.
9. Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J and Whelan S: Head and neck cancer: A global perspective on epidemiology and prognosis. Anticancer Res 18(6B): 4779-4786, 1998.
10. Idris AM, Ahmed HM and Malik MO: Toombak dipping and cancer of the oral cavity in the Sudan: A case-control study. Int J Cancer 63(4): 477-480, 1995.
11. Amarasinghe HK, Usgodaarachchi US, Johnson NW, Lalloo R and Warnakulasuriya S: Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: A case-control study. Oral Oncol 46(4): 297-301, 2010.
12. Idris AM, Ibrahim SO, Vasstrand EN, Johannessen AC, Lillehaug JR, Magnusson B, Wallstrom M, Hirsch JM and Nilsen: The Swedish snus and the Sudanese toombak: are they different? Oral Oncol 34(6): 558-66, 1998.
13. Warner GC, Reis PP, Makitie AA, Sukhai MA, Arora S, Jurisica I, Wells RA, Gullane P, Irish J, and Kamel-Reid S: Current applications of microarrays in head and neck cancer research. Laryngoscope 114(2): 241-8, 2004.
14. Kim DS and Watkinson JC: Gene chip expression analysis in head and neck cancer. Clin Otolaryngol Allied Sci 27(5): 296-303, 2002.
15. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, Wolf GT, Kuick R, Misek DE, Trask DK and Hanash S: Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130(3): 295-302, 2004.
16. Belbin TJ, Singh B, Barber I, Socci N, Wenig B, Smith R, Prystowsky MB and Childs G: Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 62(4): 1184-1190, 2000.
17. Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE, Ondrey FG, Adams GL and Gaffney PM: Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 64(1): 55-63, 2004.
18. Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S, Liotta LA, Emmert-Buck M and Gutkind JS: Distinct pattern of expression of differentiation and growthrelated genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19(28): 3220-3224, 2000.
19. Garnis C, Campbell J, Zhang L, Rosin MP and Lam WL: OCGR array: An oral cancer genomic regional array for comparative genomic hybridization analysis. Oral Oncol 40(5): 511-519, 2004.
20. Ibrahim SO, Aarsaether N, Holsve MK, Kross KW, Heimdal JH, Aarstad JH, Liavaag PG, Elgindi OA, Johannessen AC, Lillehaug JR and Vasstrand EN: Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: The case of the Sudan vs. Norway. Oral Oncol 39(1): 37-48, 2003.
21. Calvo KR, Liotta LA and Petricoin EF: Clinical proteomics: From biomarker discovery and cell signaling profiles to individualized personal therapy. Biosci Rep 25(1-2): 107-125, 2005.
22. Lunde ML, Warnakulasuriya S, Sand L, Hirsch JM, Vasstrand EN and Ibrahim SO: Gene expression analysis by cDNA microarray in oral cancers from two Western populations. Anticancer Res 30(4): 1083-1091, 2010.
23. Roman E, Meza-Zepeda LA, Kresse SH, Myklebost O, Vasstrand EN and Ibrahim SO: Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization. Oncol Rep 20(4): 825-843, 2008.
24. Ibrahim SO, Miron T, Krohn M, Amaratunga AN, Warnakulasauriya S and Vasstrand EN: Tumour-associated Proteins in Oral Squamous Cell Carcinomas by Proteomics. CGP 2: 353-364, 2005.
25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259): 680-685, 1970.
26. Jou YJ, Lin CD, Lai CH, Chen CH, Kao JY, Chen SY, Tsai MH, Huang SH and Lin CW: Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal Chimi Acta 681(1-2): 41-48, 2010.
27. Jarai T, Maasz G, Burian A, Bona A, Jambor E, Gerlinger I and Mark L: Mass spectrometry-based salivary proteomics for the discovery of head and neck squamous cell carcinoma. Pathol Oncol Res 18(3): 623-628, 2012.
28. Mills AM, Beck AH, Montgomery KD, Zhu SX, Espinosa I, Lee CH, Subramanian S, Fletcher CD, van de Rijn M and West RB: Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry. Am J Surgi Pathol 35(4): 583-589, 2011.
29. Jeong HC, Kim GI, Cho SH, Lee KH, Ko JJ, Yang JH and Chung KH: Proteomic analysis of human small cell lung cancer tissues: up-regulation of coactosin-like protein-1. J Proteome Res 10(1): 269-276, 2011.
30. Costantini V and Zacharski LR: The role of fibrin in tumor metastasis. Cancer Metastasis Rev 11(3-4): 283-290, 1992.
31. Costantini V and Zacharski LR: Fibrin and cancer. Thromb Haemost 69(5): 406-414, 1993.
32. Wang A, Liu X, Sheng S, Ye H, Peng T, Shi F, Crowe DL and Zhou X: Dysregulation of heat shock protein expression in oral tongue squamous cell carcinoma. BMC Cancer 9: 167, 2009.
33. Zhu Z, Xu X, Yu Y, Graham M, Prince ME, Carey TE and Sun D: Silencing heat shock protein decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro. Mol Pharmaceut 7(4): 1283-1290, 2010.
34. Suzuki H, Sugimura H and Hashimoto K: Overexpression of heat shock protein is associated with good prognosis in the patient with oral squamous cell carcinoma. Br J Oral Maxillofac Surg 45(2): 123-129, 2007.
35. Remotti F, Fetsch JF and Miettinen M: Keratin 1 expression in endothelia and mesenchymal tumors: An immunohistochemical analysis of normal and neoplastic tissues. Hum Pathol 32(8): 873-879, 2001.
36. Tang XH, Knudsen B, Bemis D, Tickoo S and Gudas LJ: Oral cavity and esophageal carcinogenesis modeled in carcinogentreated mice. Clin Cancer Res 10(1 Pt 1): 301-313, 2004.
37. Zhong LP, Wei KJ, Yang X, Zhang L, Zhou XJ, Pan HY, Li J, Chen WT and Zhang ZY: Increased expression of Annexin A2 in oral squamous cell carcinoma. Arch Oral Biol 54(1): 17-25, 2009.
38. Kirshner J, Schumann D and Shively JE: CEACAM1, a cell-cell adhesion molecule, directly associates with annexin II in a threedimensional model of mammary morphogenesis. J Biol Chem 278(50): 50338-50345, 2003.
39. Gerke V and Weber K: The regulatory chain in the p36-kd substrate complex of viral tyrosine-specific protein kinases is related in sequence to the S-100 protein of glial cells. EMBO J 4(11): 2917-2920, 1985.
40. Rety S, Sopkova J, Renouard M, Osterloh D, Gerke V, Tabaries S, Russo-Marie F and Lewit-Bentley A: The crystal structure of a complex of p11 with the annexin II N-terminal peptide. Nat Struct Biol 6(1): 89-95, 1999.
41. Puisieux A, Ji J and Ozturk M: Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanisms. Biochem J 313(Pt 1): 51-55, 1996.
42. Wehder L, Arndt S, Murzik U, Bosserhoff AK, Kob R, von Eggeling F and Melle C: Annexin A5 is involved in migration and invasion of oral carcinoma. Cell Cycle 8(10): 1552-1558, 2009.
43. Lee EK, Cho H and Kim CW: Proteomic analysis of cancer stem cells in human prostate cancer cells. Biochem Biophys Res Comm 412(2): 279-285, 2011.
44. Nikitakis NG, Rivera H, Lopes MA, Siavash H, Reynolds MA, Ord RA and Sauk JJ: Immunohistochemical expression of angiogenesis-related markers in oral squamous cell carcinomas with multiple metastatic lymph nodes. Am J Clin Pathol 119(4): 574-586, 2003.
45. Lin WH, Chen IH, Wei FC, Huang JJ, Kang CJ, Hsieh LL, Wang HM and Huang SF: Clinical significance of preoperative squamous cell carcinoma antigen in oral-cavity squamous cell carcinoma. Laryngoscope 121(5): 971-977, 2011.
46. Feng XY, Li JH, Li JZ, Han ZX and Xing RD: Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma. Int J Biol Mark 25(2): 93-98, 2010.
47. Lin WH, Chen IH, Wei FC, Huang JJ, Kang CJ, Hsieh LL, Wang HM and Huang SF: Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer. Oral Oncol 42(1): 26-31, 2006.
48. Ou K, Seow TK, Liang RC, Ong SE and Chung MC: Proteome analysis of a human heptocellular carcinoma cell line, HCC-M: An update. Electrophoresis 22(13): 2804-2811, 2001.